January 9, 2025 – Talk Bio

Shoreline Biosciences Reduces Staff Amid Uncertainty in Partnership with Gilead’s Kite

3 months ago talkbio0Tagged Biosciences, Cell Therapy, Gilead Sciences, Kite Pharma, Shoreline, strategic partnership

Shoreline Biosciences, Gilead Sciences, Kite Pharma, layoffs, cell therapy, strategic partnership

Elinzanetant Shows Promise in Reducing Hot Flashes in Women Undergoing Breast Cancer Therapy

3 months ago talkbio0Tagged adjuvant endocrine therapy, Elinzanetant, Hot flushes, Malignant neoplasm of breast, Non-Hormonal, Symptoms aspect, Vasomotor

Elinzanetant, Vasomotor Symptoms, Breast Cancer, Adjuvant Endocrine Therapy, Hot Flashes, Non-Hormonal Treatment

Synaffix Expands ADC Licensing Partnerships with Boehringer Ingelheim and Mitsubishi Tanabe

3 months ago talkbio0Tagged Boehringer, Cancer Therapeutic Procedure, Ingelheim, licensing agreement, Mitsubishi Tanabe, Neoplasms, Synaffix, Technology, therapeutic autologous dendritic cells

Synaffix, Boehringer Ingelheim, Mitsubishi Tanabe, ADC technology, oncology, cancer treatment, licensing agreement

Tenpoint Therapeutics Announces Breakthrough Phase 3 Results for Presbyopia Treatment Following Merger with Visus

3 months ago talkbio0Tagged BRIMOCHOL, Eye, fluorouracil/melphalan, Phase 3 trial, presbyopia, Tenpoint Therapeutics, vision drug, Visus merger

Tenpoint Therapeutics, Visus merger, Phase 3 trial, presbyopia treatment, BRIMOCHOL PF, vision drug, ophthalmic therapeutics

Astellas Terminates Development of Autologous Cell Therapy for Lymphoma Following Pipeline Review

3 months ago talkbio0Tagged Astellas, Autologous (qualifier value), Biotechnology, Cancer Therapeutic Procedure, CAR-T, Cell Therapy, Lymphoma, Pipeline Review

Astellas, lymphoma, CAR-T cell therapy, autologous cell therapy, pipeline review, cancer treatment, biotechnology

Mendaera Appoints Eric Davidson as Chief Commercial Officer to Lead Handheld Medical Robot Launch

3 months ago talkbio0Tagged Aortic Valve Insufficiency, Commercial Officer, Eric Davidson, handheld medical robot, Interventional radiology, medical robotics, Mendaera

Mendaera, handheld medical robot, chief commercial officer, Eric Davidson, medical robotics, AI, interventional radiology

National Resilience Lays Off 120 Employees at Former Bluebird Bio Gene Therapy Facility in Durham, North Carolina

3 months ago talkbio0Tagged Bio, biotech industry, CDMO, Contract Development, Durham/, Family Turdidae (organism), gene therapy, layoffs, Manufacturing Organization, National Resilience, North Carolina

National Resilience, Layoffs, Gene Therapy, Bluebird Bio, Durham/ North Carolina, Biotech Industry, CDMO (Contract Development and Manufacturing Organization)

Scribe Therapeutics Prepares for Clinical Trials by Streamlining Workforce Amid Advances in Cardiometabolic Genetic Medicines

3 months ago talkbio0Tagged cardiometabolic disease, Clinical Trials, Clustered Regularly Interspaced Short Palindromic Repeats, epigenetic modification, Gene Modification

Scribe Therapeutics, cardiometabolic disease, CRISPR, gene editing, epigenetic modification, clinical trials, workforce reduction

Velia Therapeutics Closes Operations, Remains Committed to Microprotein Therapeutic Potential

3 months ago talkbio0Tagged Biotechnology, company closure, microproteins, Velia

Velia Therapeutics, microproteins, biotechnology, therapeutic potential, company closure

Novo Nordisk and Lilly Lead Clarivate’s 2025 ‘Drugs to Watch’ List with Breakthrough Therapies

3 months ago talkbio0Tagged blockbuster drugs, Clarivate, Drug Industry, Eli, Eli Lilly, gene therapy, Neoplasms, Nordisk, Obesity

Clarivate, Drugs to Watch 2025, Novo Nordisk, Eli Lilly, Obesity treatments, Gene therapy, Oncology, Blockbuster drugs, Pharmaceutical industry